focus -WSS

focus

author：Wikipedia 2025-08-23 21:53:38 - browse：6

Is biotech back from its downturn? Can Nvidia solve biology? And is it wise to do a deal on a party bus?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recording from the J.P. Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024. We also talk about the latest twist in the Sarepta Therapeutics saga, a ubiquitous dealmaker, and life on the party circuit.

For more on what we cover, here’s the news on Sarepta; here’s more on Nvidia; here’s the story on Centerview; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Maisha Meds is a PBM, but don't call it that

explore

WSS

To bolster infectious disease surveillance, genomics powerhouses team up

A pediatrician calls for Congress to pass the child tax credit deal

TikTok, Instagram influencers need more rules for drug ads

Decentralized clinical trials need collaboration to achieve wider use

Some medical students still think black patients feel less pain

TikTok, Instagram influencers need more rules for drug ads

knowledge

focus

focus

Drug repurposing or repositioning? The language matters

Immunocompromised patients offer clues on chronic Covid

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Stroke rates rising, especially in working

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

What causes osteoarthritis? Researchers study link to brain protein

Sports medicine is finally prioritizing gender equality

Medicare drug price lawsuits could be good politics for Biden

Medicare proposal to cover medical devices draws a mixed reaction

Stroke rates rising, especially in working

entertainment

Louisiana bill approved classifying abortion pills as controlled substances

Flu vaccine reformulation won't be easy, manufacturers warn

Ozempic cut risk of death in diabetes patients with chronic kidney disease

FDA sets aggressive timeline for overhauling inspection procedures

Dana Farber says 6 studies to be retracted and 31 corrected

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

hotspot

hotspot

explore

hotspot